McKeown September 20, As time goes by, patients treated with off-pump CABG surgery have higher mortality, less complete revascularization, and more need for repeat revascularization in the ensuing years than those treated with an on-pump approach, new real-world data suggest. The trial has been criticized for having a predominantly male population and for allowing large numbers of inexperienced residents to perform procedures.
Email A type of heartburn medication called proton pump inhibitors may be linked to long-term kidney damage, a new study suggests. Prilosec, Nexium and Prevacid belong to this class of drugs, which treat heartburn and acid reflux by lowering the amount of acid produced by the stomach.
People who use proton pump inhibitors PPIs have a 20 percent to 50 percent higher risk of chronic kidney disease compared with nonusers, said lead author Dr.
The study was published Jan. The study doesn't establish a direct cause-and-effect relationship between the drugs and chronic kidney disease. However, Grams said, "We found there was an increasing risk associated with an increasing dose.
That suggests that perhaps this observed effect is real. But as many as 70 percent of these prescriptions have been handed out inappropriately, and 25 percent of long-term users could stop taking the medication without suffering increased heartburn or acid refluxthe study authors said.
Use of the prescription heartburn drugs already has been linked to short-term kidney problems such as acute kidney injury and an inflammatory kidney disease called acute interstitial nephritis, Grams said.
Newer studies now show a link between the drugs and chronic kidney disease, in which the kidneys lose their ability to filter blood effectively. Over time, chronic kidney disease can lead to kidney failure, forcing someone to undergo regular dialysis and possibly a kidney transplant, according to the U.
National Institutes of Health. In this new study, researchers used data on self-reported proton pump inhibitors use among more than 10, people taking part in a national study on hardening of the arteries. The researchers also evaluated data on outpatient PPI prescriptions among nearlypatients of a health care system in Pennsylvania.
From the start, PPI users in both groups were more likely to have health problems, such as obesity, high blood pressure and heart problems, the study noted.
In both groups, researchers associated use of the drugs with an increased risk of chronic kidney disease over 10 years. The researchers also compared people using the drugs once a day with people who used them twice a day.
They found twice-daily use was associated with a 46 percent increased risk of chronic kidney disease, versus a 15 percent increased risk in those taking one daily dose. No one is sure how the drugs might damage the kidneys, but a couple of leading theories exist, Grams said.
The medications can cause magnesium levels to decline in the body, and a lack of this important mineral could damage the kidneys.
The kidneys also might become damaged over time if patients suffer repeated bouts of acute kidney inflammation due to proton pump inhibitors. Gastroenterologists already are cautious regarding the use of the drugs, because they've been tied to other health problems such as bone fractures and infections of C.
Because the new study isn't a clinical trial, it doesn't prove that PPI use causes chronic kidney disease, said Dr. It's possible that the drug users suffer chronic kidney disease more often because they have overall poorer health, he said. Grams said the study authors tried to address that concern by comparing PPI users to people using another heartburn medication called H2 blockers.
Both patient groups tended to be equally unhealthy, but PPI users had a 39 percent higher risk of chronic kidney disease, the researchers said. While this study shouldn't lead anyone to knee-jerk stop using proton pump inhibitors, people who use them regularly should talk with their doctor about whether they really need them, Grams and DeVault said.
This material may not be published, broadcast, rewritten, or redistributed.Postperfusion syndrome, also known as "pumphead", is a constellation of neurocognitive impairments attributed to cardiopulmonary bypass (CPB) during cardiac surgery.
Subsequent studies have compared "on-pump" CABG to off-pump coronary artery bypass (OPCAB). Appendix E Pump Test Report. GROUND-WATER EXPLORATION PROGRAM LEGACY RIDGE, TOWN OF WOODBURY, NEW YORK in on the study parcel developed three successful sand and gravel production wells identified as TW-1, TW-2 and TW-4; with respective yields of , and 34 gpm.
below top of casing (TOC) and the pump was set at a depth of Pump shaft failures — a compendium of case studies F. Berndta, A. van Bennekomb,* aAdvanced Engineering and Testing Services, MATTEK, CSIR, Private Bag X28, Auckland Park , South Africa bSchool of Process and Materials Engineering, University of the Witwatersrand, Private Bag 3, P.O.
WITS , South Africa Received 10 June ; accepted 26 October Study of Centrifugal Pump - Download as Word Doc .doc /.docx), PDF File .pdf), Text File .txt) or read online.
Mechanical and Civil Engineering. A Years Old leading industrial Pump Manufacturing Company with a global foot-print With their unparalleled product range across many industry segments, they are a recognized global fluid management solutions provider and the largest manufacturer & exporter of centrifugal pumps .
A total of people were being treated with insulin pump therapy during the study period from baseline to the final year, and 15 were treated with multiple daily injections during the whole study period to final year.